IDEXX Laboratories EBITDA 2010-2025 | IDXX
IDEXX Laboratories annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- IDEXX Laboratories EBITDA for the quarter ending June 30, 2025 was $0.409B, a 38.12% increase year-over-year.
- IDEXX Laboratories EBITDA for the twelve months ending June 30, 2025 was $1.393B, a 15.67% increase year-over-year.
- IDEXX Laboratories 2024 annual EBITDA was $1.258B, a 3.81% increase from 2023.
- IDEXX Laboratories 2023 annual EBITDA was $1.212B, a 19.92% increase from 2022.
- IDEXX Laboratories 2022 annual EBITDA was $1.011B, a 2.5% decline from 2021.
| IDEXX Laboratories Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,258 |
| 2023 | $1,212 |
| 2022 | $1,011 |
| 2021 | $1,037 |
| 2020 | $791 |
| 2019 | $641 |
| 2018 | $575 |
| 2017 | $496 |
| 2016 | $429 |
| 2015 | $370 |
| 2014 | $319 |
| 2013 | $321 |
| 2012 | $315 |
| 2011 | $284 |
| 2010 | $250 |
| 2009 | $226 |
| IDEXX Laboratories Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $409 |
| 2025-03-31 | $351 |
| 2024-12-31 | $295 |
| 2024-09-30 | $338 |
| 2024-06-30 | $296 |
| 2024-03-31 | $329 |
| 2023-12-31 | $275 |
| 2023-09-30 | $304 |
| 2023-06-30 | $324 |
| 2023-03-31 | $309 |
| 2022-12-31 | $255 |
| 2022-09-30 | $273 |
| 2022-06-30 | $207 |
| 2022-03-31 | $275 |
| 2021-12-31 | $227 |
| 2021-09-30 | $252 |
| 2021-06-30 | $285 |
| 2021-03-31 | $273 |
| 2020-12-31 | $210 |
| 2020-09-30 | $197 |
| 2020-06-30 | $217 |
| 2020-03-31 | $168 |
| 2019-12-31 | $138 |
| 2019-09-30 | $162 |
| 2019-06-30 | $186 |
| 2019-03-31 | $154 |
| 2018-12-31 | $136 |
| 2018-09-30 | $138 |
| 2018-06-30 | $166 |
| 2018-03-31 | $134 |
| 2017-12-31 | $119 |
| 2017-09-30 | $121 |
| 2017-06-30 | $143 |
| 2017-03-31 | $113 |
| 2016-12-31 | $105 |
| 2016-09-30 | $108 |
| 2016-06-30 | $124 |
| 2016-03-31 | $92 |
| 2015-12-31 | $85 |
| 2015-09-30 | $91 |
| 2015-06-30 | $105 |
| 2015-03-31 | $89 |
| 2014-12-31 | $50 |
| 2014-09-30 | $88 |
| 2014-06-30 | $98 |
| 2014-03-31 | $83 |
| 2013-12-31 | $75 |
| 2013-09-30 | $79 |
| 2013-06-30 | $93 |
| 2013-03-31 | $75 |
| 2012-12-31 | $77 |
| 2012-09-30 | $76 |
| 2012-06-30 | $89 |
| 2012-03-31 | $73 |
| 2011-12-31 | $68 |
| 2011-09-30 | $68 |
| 2011-06-30 | $83 |
| 2011-03-31 | $65 |
| 2010-12-31 | $63 |
| 2010-09-30 | $61 |
| 2010-06-30 | $66 |
| 2010-03-31 | $60 |
| 2009-12-31 | $57 |
| 2009-09-30 | $57 |
| 2009-06-30 | $61 |
| 2009-03-31 | $51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.647B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.802B | 22.84 |
| Intuitive Surgical (ISRG) | United States | $170.692B | 70.75 |
| Edwards Lifesciences (EW) | United States | $48.042B | 31.84 |
| Alcon (ALC) | Switzerland | $40.456B | 27.16 |
| IQVIA Holdings (IQV) | United States | $32.496B | 18.36 |
| DexCom (DXCM) | United States | $32.259B | 48.39 |
| Mettler-Toledo (MTD) | United States | $27.221B | 32.31 |
| STERIS (STE) | Ireland | $24.807B | 26.40 |
| Waters (WAT) | United States | $17.988B | 24.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.319B | 0.00 |
| Hologic (HOLX) | United States | $15.182B | 16.45 |
| Penumbra (PEN) | United States | $10.325B | 75.42 |
| Globus Medical (GMED) | United States | $8.444B | 19.48 |
| Sysmex ADR (SSMXY) | Japan | $8.410B | 26.72 |
| Masimo (MASI) | United States | $8.074B | 27.17 |
| Teleflex (TFX) | United States | $5.719B | 9.23 |
| Glaukos (GKOS) | United States | $5.400B | 0.00 |
| TransMedics (TMDX) | United States | $4.086B | 62.10 |
| Integer Holdings (ITGR) | United States | $3.874B | 19.33 |
| LivaNova (LIVN) | United Kingdom | $3.052B | 17.47 |
| Veracyte (VCYT) | United States | $2.439B | 33.70 |
| Alphatec Holdings (ATEC) | United States | $2.388B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.294B | 0.00 |
| Artivion (AORT) | United States | $2.115B | 106.74 |
| Elekta AB (EKTAY) | Sweden | $1.924B | 18.00 |
| Nihon Kohden (NHNKY) | Japan | $1.914B | 22.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.158B | 6.63 |
| Pulse Biosciences (PLSE) | United States | $1.147B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| IRadimed (IRMD) | United States | $0.924B | 44.85 |
| Tandem Diabetes Care (TNDM) | United States | $0.806B | 0.00 |
| AxoGen (AXGN) | United States | $0.748B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.707B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.543B | 9.60 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.465B | 3.74 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.401B | 10.20 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| RxSight (RXST) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.304B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.295B | 20.35 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.268B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.221B | 0.00 |
| Inogen (INGN) | United States | $0.210B | 0.00 |
| CVRx (CVRX) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.125B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.082B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.008B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.54 |